Maravai LifeSciences Holdings Inc (NAS:MRVI)
$ 5.92 0.3 (5.34%) Market Cap: 839.71 Mil Enterprise Value: 780.08 Mil PE Ratio: 0 PB Ratio: 2.43 GF Score: 74/100

Maravai LifeSciences Holdings Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 13, 2021 / 07:30PM GMT
Release Date Price: $45.55 (-3.25%)
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

Good afternoon, everyone. Thanks for joining us today on day 3 of our Healthcare Conference. I'm Tejas Savant, and I cover the life science tools and diagnostics sector at Morgan Stanley. Delighted to have Maravai join us today. And representing the company, we have Carl Hull, CEO; and Kevin Herde, CFO. Welcome to you both, gents.

Before we get into the Q&A, just some important disclosures. Please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your sales rep.

Questions & Answers

Tejas Rajeev Savant;Carl W. Hull
Morgan Stanley, Research Division - Equity Analyst;Maravai

So with that, Carl, I mean, just to kick things off, maybe for people on the call who are not as familiar with the Maravai story, can you give us a high-level overview of the company? And what do you view as Maravai's greatest accomplishments since the IPO last year?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot